Cargando…

Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the leading lethal tumors worldwide, and the treatment remains a great medical challenge. Surgery and chemotherapy are current standard curative methods for patients with HCC, but the prognosis is still dismal. Based on unique medical theories and rich practi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yuyao, Li, Yue, Zhang, Jinghao, Ji, Longshan, Li, Man, Sun, Xuehua, Feng, Hai, Yu, Zhuo, Gao, Yueqiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843800/ https://www.ncbi.nlm.nih.gov/pubmed/35178363 http://dx.doi.org/10.2147/JHC.S346047

Ejemplares similares

Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine
por: Zhou, Zhijia, et al.
Publicado: (2022)

Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma
por: Yu, Zhuo, et al.
Publicado: (2022)

Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Potentilla discolor Bunge
por: Ji, Longshan, et al.
Publicado: (2022)

A novel association of pyroptosis-related gene signature with the prognosis of hepatocellular carcinoma
por: Li, Yuyao, et al.
Publicado: (2022)

Antifungal and Immunomodulatory Ingredients from Traditional Chinese Medicine
por: Zhong, Hua, et al.
Publicado: (2022)

Active ingredients of traditional Chinese medicine for enhancing the effect of tumor immunotherapy
por: Yang, Chao, et al.
Publicado: (2023)

Tumor Microenvironment in Hepatocellular Carcinoma: Key Players for Immunotherapy
por: Feng, Hai, et al.
Publicado: (2022)

Advances of multi-omics applications in hepatic precancerous lesions and hepatocellular carcinoma: The role of extracellular vesicles
por: Lu, Xiaona, et al.
Publicado: (2023)

Effects of Traditional Chinese Medicine and its Active Ingredients on Drug-Resistant Bacteria
por: Li, Jimin, et al.
Publicado: (2022)

In silico Identification and Mechanism Exploration of Hepatotoxic Ingredients in Traditional Chinese Medicine
por: Wu, Qihui, et al.
Publicado: (2019)

Improvement influenza vaccine immune responses with traditional Chinese medicine and its active ingredients
por: Zhao, Danping, et al.
Publicado: (2023)

Smart Targeted Delivery Systems for Enhancing Antitumor Therapy of Active Ingredients in Traditional Chinese Medicine
por: Kang, Chenglong, et al.
Publicado: (2023)

Regulation of transient receptor potential channels by traditional Chinese medicines and their active ingredients
por: Yan, Shidu, et al.
Publicado: (2022)

Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicine
por: Yao, Man, et al.
Publicado: (2023)

Practitioners’ perspectives on evaluating treatment outcomes in traditional Chinese medicine
por: Zhang, Yan-Hong, et al.
Publicado: (2017)

Frontier progress of the combination of modern medicine and traditional Chinese medicine in the treatment of hepatocellular carcinoma
por: Wei, Lai, et al.
Publicado: (2022)

Data-mining of potential antitubercular activities from molecular ingredients of traditional Chinese medicines
por: Jamal, Salma, et al.
Publicado: (2014)

Perturbed autophagy intervenes systemic lupus erythematosus by active ingredients of traditional Chinese medicine
por: Tian, Rui, et al.
Publicado: (2023)

The role of ferroptosis in diabetic cardiovascular diseases and the intervention of active ingredients of traditional Chinese medicine
por: Zhang, Xiaobing, et al.
Publicado: (2023)

Current Status of Standardization of Traditional Chinese Medicine in China
por: Wang, Juan, et al.
Publicado: (2016)

Antitumor Research of the Active Ingredients from Traditional Chinese Medical Plant Polygonum Cuspidatum
por: Wu, Xinnan, et al.
Publicado: (2018)

Systematic analysis of the role and significance of target genes of active ingredients of traditional Chinese medicine injections in the progression and immune microenvironment of hepatocellular carcinoma
por: Wang, Chao, et al.
Publicado: (2023)

Integrating bulk and single-cell RNA sequencing data to establish necroptosis-related lncRNA risk model and analyze the immune microenvironment in hepatocellular carcinoma
por: Zhang, Rongjie, et al.
Publicado: (2023)

Targeting immunometabolism by active ingredients derived from traditional Chinese medicines for treatment of rheumatoid arthritis
por: He, Yu-fei, et al.
Publicado: (2021)

Perspectives of traditional Chinese medicine in pancreas protection for acute pancreatitis
por: Li, Jun, et al.
Publicado: (2017)

Current Usage of Traditional Chinese Medicine in the Management of Breast Cancer: A Practitioner’s Perspective
por: McPherson, Luke, et al.
Publicado: (2015)

Activation of apoptosis in hepatocellular carcinoma by the Chinese traditional medicine Hu Qisan
por: ZENG, XIANGJUN, et al.
Publicado: (2013)

Active Ingredients from Chinese Medicine for Combination Cancer Therapy
por: Wang, Xuan, et al.
Publicado: (2023)

Research Progress on Autophagy Regulation by Active Ingredients of Traditional Chinese Medicine in the Treatment of Acute Lung Injury
por: Dong, Jin-yan, et al.
Publicado: (2023)

Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis
por: Lu, Xiaona, et al.
Publicado: (2023)

Is Traditional Chinese Medicine “Mainstream” in China? Trends in Traditional Chinese Medicine Health Resources and Their Utilization in Traditional Chinese Medicine Hospitals from 2004 to 2016
por: Shi, Xuefeng, et al.
Publicado: (2020)

Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2
por: Du, Ashuai, et al.
Publicado: (2021)

Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation
por: Wang, Tao, et al.
Publicado: (2022)

Role of traditional Chinese medicine in the management of patients with hepatocellular carcinoma
por: Xi, Sheng-Yan, et al.
Publicado: (2018)

System-level Study on Synergism and Antagonism of Active Ingredients in Traditional Chinese Medicine by Using Molecular Imprinting Technology
por: Chen, Tengfei, et al.
Publicado: (2014)

New Therapeutic Horizon of Graves’ Hyperthyroidism: Treatment Regimens Based on Immunology and Ingredients From Traditional Chinese Medicine
por: He, Qiongyao, et al.
Publicado: (2022)

Traditional Chinese and Thai medicine in a comparative perspective
por: He, Ke
Publicado: (2015)

Simultaneous Quantification of 11 Phenolic Compounds and Consistency Evaluation in Four Dendrobium Species Used as Ingredients of the Traditional Chinese Medicine Shihu
por: Zhu, An-Ling, et al.
Publicado: (2021)

Spectrum-Effect Relationships as a Systematic Approach to Traditional Chinese Medicine Research: Current Status and Future Perspectives
por: Xu, Guan-Ling, et al.
Publicado: (2014)

Traditional medicines and globalization: current and future perspectives in ethnopharmacology
por: Leonti, Marco, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bqbulnqbdr2iuc3aogfimr5o12